A Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometric Assay for the Quantification of Fabry Disease Biomarker Globotriaosylceramide (GB3) in Fabry Model Mouse.
Pharmaceutics
; 10(2)2018 Jun 07.
Article
in En
| MEDLINE
| ID: mdl-29880732
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Pharmaceutics
Year:
2018
Document type:
Article